Posted by: admin on: September 22, 2011
The US Food and Drug Administration (FDA) has approved icatibant subcutaneous injection (Firazyr) for the treatment of acute attacks of hereditary angioedema (HAE) in adults aged 18 years and older. -Team@CMHF
Enter your email address:
This Widget requires Javascript
Height in cm:
Weight in kg:
Your BMI is .
Check your Body Mass Index »